Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047723 · ClinicalTrials.gov registry record · Phase 3
Minocycline to Treat Amyotrophic Lateral Sclerosis
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
NCT00047723 is a Phase 3 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 400 participants.
The verdict
NCT00047723, a Phase 3 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
Study Summary
The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
Interventions
- DRUG minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2003-01 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047723
The ClinicalTrials.gov registry entry for NCT00047723 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which minocycline is the first listed.
NCT00047723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00047723 about?
NCT00047723 is a clinical study titled "Minocycline to Treat Amyotrophic Lateral Sclerosis". The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
What is the current status of trial NCT00047723?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2003-01. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00047723?
The interventions under investigation include: minocycline (DRUG).
Who is sponsoring clinical trial NCT00047723?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.